6.67
price up icon1.52%   0.10
after-market Handel nachbörslich: 6.26 -0.41 -6.15%
loading
Schlusskurs vom Vortag:
$6.57
Offen:
$6.62
24-Stunden-Volumen:
1.05M
Relative Volume:
1.07
Marktkapitalisierung:
$334.18M
Einnahmen:
$124.00K
Nettoeinkommen (Verlust:
$-49.99M
KGV:
-3.9467
EPS:
-1.69
Netto-Cashflow:
$-31.03M
1W Leistung:
+6.72%
1M Leistung:
+40.42%
6M Leistung:
-2.49%
1J Leistung:
+10.61%
1-Tages-Spanne:
Value
$6.28
$6.68
1-Wochen-Bereich:
Value
$6.28
$7.25
52-Wochen-Spanne:
Value
$3.785
$14.60

Candel Therapeutics Inc Stock (CADL) Company Profile

Name
Firmenname
Candel Therapeutics Inc
Name
Telefon
617-916-5445
Name
Adresse
117 KENDRICK STREET, NEEDHAM
Name
Mitarbeiter
38
Name
Twitter
Name
Nächster Verdiensttermin
Name
Neueste SEC-Einreichungen
Name
CADL's Discussions on Twitter

Vergleichen Sie CADL mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
CADL
Candel Therapeutics Inc
6.67 313.14M 124.00K -49.99M -31.03M -1.69
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
470.13 119.21B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
560.93 59.16B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
325.28 40.57B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
571.23 34.02B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
295.59 29.19B 3.81B -644.79M -669.77M -6.24

Candel Therapeutics Inc Stock (CADL) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-06-30 Fortgesetzt H.C. Wainwright Buy
2025-02-20 Eingeleitet Citigroup Buy
2025-02-19 Eingeleitet Canaccord Genuity Buy
2025-02-07 Eingeleitet BofA Securities Buy
2022-12-02 Eingeleitet H.C. Wainwright Buy
2021-11-19 Eingeleitet BMO Capital Markets Outperform
2021-08-23 Eingeleitet Credit Suisse Outperform
2021-08-23 Eingeleitet Jefferies Buy
2021-08-23 Eingeleitet UBS Buy
Alle ansehen

Candel Therapeutics Inc Aktie (CADL) Neueste Nachrichten

pulisher
Jul 22, 2025

Candel Therapeutics Inc. Stock Analysis and ForecastUnbelievable profit margins - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

What analysts say about Candel Therapeutics Inc. stockFree Stock Market Knowledge Sharing - Autocar Professional

Jul 22, 2025
pulisher
Jul 22, 2025

(CADL) Trading Report - news.stocktradersdaily.com

Jul 22, 2025
pulisher
Jul 22, 2025

Is Candel Therapeutics Inc. a good long term investmentRapid growth opportunities - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 20, 2025

What drives Candel Therapeutics Inc. stock priceExceptional earning trajectories - jammulinksnews.com

Jul 20, 2025
pulisher
Jul 17, 2025

What makes Candel Therapeutics Inc. stock price move sharplyShort Squeeze Radar - beatles.ru

Jul 17, 2025
pulisher
Jul 16, 2025

Candel Therapeutics (CADL) Shares Soar 9.60% - AInvest

Jul 16, 2025
pulisher
Jul 15, 2025

Candel Therapeutics (CADL) Has a New Rating from Freedom Capital Markets - The Globe and Mail

Jul 15, 2025
pulisher
Jul 14, 2025

Freedom Broker initiates coverage on Candel Therapeutics stock with Buy rating - Investing.com Nigeria

Jul 14, 2025
pulisher
Jul 14, 2025

Freedom Broker initiates coverage on Candel Therapeutics stock with Buy rating By Investing.com - Investing.com South Africa

Jul 14, 2025
pulisher
Jul 11, 2025

(CADL) Investment Report - news.stocktradersdaily.com

Jul 11, 2025
pulisher
Jul 10, 2025

Brookline Capital Initiates Candel Therapeutics(CADL.US) With Buy Rating, Announces Target Price $25 - 富途牛牛

Jul 10, 2025
pulisher
Jul 10, 2025

Candel Therapeutics Added to Russell Indexes, Analysts Forecast Upside of 319.85% - AInvest

Jul 10, 2025
pulisher
Jul 10, 2025

Candel Therapeutics added to multiple Russell value indexes By Investing.com - Investing.com South Africa

Jul 10, 2025
pulisher
Jul 09, 2025

Brookline Capital initiates Candel Therapeutics stock with Buy rating, $25 target - Investing.com Nigeria

Jul 09, 2025
pulisher
Jul 09, 2025

Candel Therapeutics Added To Multiple Russell Value Indexes In 2025 Reconstitution - 富途牛牛

Jul 09, 2025
pulisher
Jul 09, 2025

Market movers: Meta, Nvidia, Candel Therapeutics, Ocean Power Technologies... - Proactive financial news

Jul 09, 2025
pulisher
Jul 09, 2025

Candel Therapeutics: Russell Inclusion and Clinical Catalysts Drive Biotech Upside - AInvest

Jul 09, 2025
pulisher
Jul 09, 2025

Candel Therapeutics Expands Russell Index Presence with Addition to Multiple Value-Oriented Indexes in 2025 Reconstitution - The Manila Times

Jul 09, 2025
pulisher
Jul 09, 2025

Candel Therapeutics added to multiple Russell value indexes - Investing.com

Jul 09, 2025
pulisher
Jul 09, 2025

Candel Therapeutics, Inc. Gains Inclusion in Multiple Russell Value Indexes During 2025 Annual Reconstitution - Quiver Quantitative

Jul 09, 2025
pulisher
Jul 09, 2025

Candel Therapeutics Expands Russell Index Presence with - GlobeNewswire

Jul 09, 2025
pulisher
Jul 09, 2025

Candel Therapeutics expands Russell Index presence following 2025 reconstitution - Proactive financial news

Jul 09, 2025
pulisher
Jun 30, 2025

Candel Therapeutics stock initiated with Buy rating at H.C. Wainwright - Investing.com India

Jun 30, 2025
pulisher
Jun 27, 2025

One Candel Therapeutics Insider Raised Stake By 22% In Previous Year - Yahoo Finance

Jun 27, 2025
pulisher
Jun 25, 2025

Candel Therapeutics (CADL) Upgraded to Strong Buy: Here's What You Should Know - Yahoo Finance

Jun 25, 2025
pulisher
Jun 24, 2025

Market movers: Carnival, Uber, Ideal Power, Candel Therapeutics... - Proactive Investors

Jun 24, 2025
pulisher
Jun 23, 2025

Candel Therapeutics names Charles Schoch as CFO after interim tenure - Proactive financial news

Jun 23, 2025
pulisher
Jun 23, 2025

Candel Therapeutics Appoints Charles Schoch as Chief Financial Officer - The Globe and Mail

Jun 23, 2025
pulisher
Jun 21, 2025

Trend Tracker for (CADL) - news.stocktradersdaily.com

Jun 21, 2025
pulisher
Jun 18, 2025

Candel Therapeutics Elects New Directors at Annual Meeting - TipRanks

Jun 18, 2025
pulisher
Jun 15, 2025

Candel Therapeutics, Inc.'s (NASDAQ:CADL) latest 15% decline adds to one-year losses, institutional investors may consider drastic measures - simplywall.st

Jun 15, 2025
pulisher
Jun 13, 2025

Neoantigen Cancer Vaccines Industry Analysis Report 2025 with Tariff-Adjusted Forecasts and Analytics to 2030 - GlobeNewswire

Jun 13, 2025
pulisher
Jun 09, 2025

Candel Therapeutics, Inc. (NASDAQ:CADL) Shares Purchased by Squarepoint Ops LLC - Defense World

Jun 09, 2025
pulisher
Jun 06, 2025

Candel Therapeutics appoints new board member ahead of BLA submission By Investing.com - Investing.com South Africa

Jun 06, 2025
pulisher
Jun 06, 2025

Small cap wrap: HIVE Digital, TNR Gold, Candel Therapeutics... - Proactive financial news

Jun 06, 2025
pulisher
Jun 06, 2025

Candel Therapeutics Appoints Maha Radhakrishnan, M.D., To Board - citybiz

Jun 06, 2025
pulisher
Jun 06, 2025

Candel Therapeutics, Inc. Appoints Maha Radhakrishnan to Its Board of Directors - marketscreener.com

Jun 06, 2025
pulisher
Jun 06, 2025

Candel Therapeutics adds biotech veteran Maha Radhakrishnan to Board - Proactive financial news

Jun 06, 2025
pulisher
Jun 06, 2025

Candel Therapeutics appoints new board member ahead of BLA submission - Investing.com

Jun 06, 2025
pulisher
Jun 06, 2025

Candel Therapeutics Appoints Maha Radhakrishnan, M.D., to its Board of Directors - GlobeNewswire

Jun 06, 2025

Finanzdaten der Candel Therapeutics Inc-Aktie (CADL)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$21.80
price up icon 0.51%
$36.10
price up icon 1.26%
$102.92
price up icon 0.14%
$26.54
price up icon 0.76%
$111.44
price up icon 2.32%
biotechnology ONC
$295.59
price up icon 1.25%
Kapitalisierung:     |  Volumen (24h):